Sporadic type composite pheochromocytoma with neuroblastoma:: Clinicomorphologic, DNA content, and ret gene analysis

被引:14
作者
Candanedo-González, FA
Alvarado-Cabrero, I
Gamboa-Domínguez, M
Cérbulo-Vászquez, A
López-Romero, R
Bornstein-Quevedo, L
Salcedo-Vargas, M
机构
[1] IMSS, Ctr Med Nacl Siglo 21, Oncol Hosp, Dept Pathol, Mexico City 06720, DF, Mexico
[2] IMSS, Ctr Med Nacl Siglo 21, Oncol Hosp, Oncol Res Unit, Mexico City 06720, DF, Mexico
[3] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Pathol, Mexico City, DF, Mexico
[4] Inst Nacl Perinatol, Flow Cytometry Unit, Mexico City, DF, Mexico
关键词
composite pheochromocytoma; neuroblastoma; adrenal medulla; DNA ploidy; ret proto-oncogene;
D O I
10.1385/EP:12:3:343
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Composite pheochromocytomas (CP) account for only 3% of all pheochromocytomas. We analyzed the clinical, immunohistochemical, ultrastructural, DNA content, and a 634 ret mutation feature in a 56-yr-old Mexican woman with a CP localized in the right adrenal gland and associated with a blood pressure of 140/90 mmHg. Clinical symptoms were absent after surgery. The tumor showed pheochromocytoma and neuroblastoma components. This dual phenotype was supported by light microscopy and corroborated by immunohistochemistry and ultrastructural findings. Flow cytometric analysis showed that both components were diploid. A genetic mutational analysis of the ret oncogene in exon 11 showed no 634 mutation. This case demonstrates the indolent behavior of neuroblastoma associated with a sporadic-type CP in an adult patient.
引用
收藏
页码:343 / 350
页数:8
相关论文
共 25 条
[1]  
ABRAMOWSKY CR, 1989, CANCER, V63, P1752
[2]   Human pheochromocytomas, but not adrenal medulla, express glucagon-receptor gene and possess an in vitro secretory response to glucagon [J].
Albertin, G ;
Aragona, F ;
Gottardo, L ;
Malendowicz, LK ;
Nussdorfer, GG .
PEPTIDES, 2001, 22 (04) :597-600
[3]  
AMODEO C, 1989, ARCH PATHOL LAB MED, V113, P800
[4]  
Brown HM, 1999, CANCER, V86, P1583, DOI 10.1002/(SICI)1097-0142(19991015)86:8<1583::AID-CNCR28>3.0.CO
[5]  
2-#
[6]  
Eng C, 1997, HUM MUTAT, V9, P97, DOI 10.1002/(SICI)1098-1004(1997)9:2<97::AID-HUMU1>3.3.CO
[7]  
2-Q
[8]  
Franks LM, 1997, CANCER, V79, P2028, DOI 10.1002/(SICI)1097-0142(19970515)79:10<2028::AID-CNCR26>3.0.CO
[9]  
2-V
[10]   CLINICAL USE OF MOLECULAR INFORMATION IN THE MANAGEMENT OF MULTIPLE ENDOCRINE NEOPLASIA TYPE 2A [J].
GAGEL, RF ;
COTE, GJ ;
BUGALHO, MJGM ;
BOYD, AE ;
CUMMINGS, T ;
GOEPFERT, H ;
EVANS, DB ;
CANGIR, A ;
KHORANA, S ;
SCHULTZ, PN .
JOURNAL OF INTERNAL MEDICINE, 1995, 238 (04) :333-341